The founders were building a new UI for their own internal software. It was their external marketing firm, not them, who recognized the tool could be packaged and sold as a standalone modernization product, which became their flagship offering.

Qualcomm's entry into the Interbrand 100 was 70% driven by turning its Snapdragon ingredient brand into a household name. This demonstrates that a B2B tech company can significantly boost its corporate brand value by investing in a consumer-facing sub-brand, even if that sub-brand's financials are not reported separately.

The PDMA's Outstanding Corporate Innovator (OCI) award involves a six-month on-site audit. Companies report that simply going through this rigorous evaluation helps them benchmark and improve their innovation systems, making the application itself a valuable exercise, regardless of winning.

Despite being in many consumer products, Novonesis avoids co-branding. They empower their customers' billion-dollar brands (e.g., P&G, Unilever) rather than building their own consumer recognition, which could complicate B2B relationships.

According to Kainova's CEO, the primary goal of a new biotech platform's first pharma partnership is not financial. It's to secure a prestigious partner name to validate the technology. This external validation, or "PR value," is more critical early on than maximizing the upfront payment, as it builds credibility for future, more lucrative deals.

Business owners often avoid publicizing awards, fearing it appears boastful. Instead, this should be framed as a celebration of the team's success and an invitation for the local community to engage and celebrate alongside them. This builds goodwill and reinforces community ties.

To sell to risk-averse CFOs without many customer logos, Briq built credibility by partnering with financial associations in their target industry. This strategy provided the necessary social proof and trust verification needed to close early deals with skeptical buyers.

Winning a 'Golden Ticket' from a major pharma company like Servier provides more than just lab space. It acts as a powerful external validation of the science, which in turn helps the startup gain credibility to win additional awards and attract investment from other major players like Eli Lilly and Ono Pharma.

Zebra Technologies, which primarily sells RFID tracking to businesses, leverages its high-profile NFL partnership for marketing. This consumer-relevant deal provides massive brand credibility that helps win traditional B2B clients like FedEx, proving that even "boring" B2B companies benefit from being seen by the public.